Abstract:Muscle diseases, or myopathies, are a group of rare congenital diseases that severely incapacitate the patients and in some cases are fatal. Most of these diseases result from mutations in genes that code for proteins of the sarcomere, the contractile unit of the muscle. In this thesis I studied two groups of myopathies, nemaline and desmin related myopathies. Although markedly distinct myopathies, the general pathological and clinical features are similar, as both nemaline and desmin myopathy patients suffer from muscle weakness and atrophy, and present disrupted muscle fibres with protein aggregates. The aggregates are however different in protein content and shape: nemaline myopathy aggregates are usually rod shaped and electron dense when visualised by electron microscopy, and often contain actin and α-actinin, while desmin myopathy aggregates are irregularly shaped and contain desmin, HSPB5, filamin C, and dystrophin. In some severe cases of nemaline myopathy patients also present with foetal akinesia, a disorder characterised by a reduction or loss of foetal movement, which is fatal in utero or shortly after birth. Nemaline myopathies result from mutations in proteins of the actin-rich thin filaments, but can also result from mutations in a non-structural protein, BTB and kelch domain-containing protein 13 (KBTBD13). KBTBD13 is a member of the BTB and kelch domain-containing family composed of more than 70 members, shown to be involved in ubiquitination of proteins. Here I describe the identification of a member of this family, kelch-like family member 40 (KLHL40), as a foetal akinesia and nemaline myopathy-causing gene. Using a zebrafish knockdown model I confirmed that mutations in KLHL40 disrupt muscle structure and function, consistent with the patients’ pathology. Additionally, I identified three other members of the BTB and kelch domain-containing family to be expressed in the skeletal muscle, klhl31, klhl41a, and klhl40b, and characterised the role of klhl31 in muscle formation and function. Using a knockdown approach I identified klhl31 as a potential nemaline myopathy with akinesia causing gene and proposed a model for how mutations in this family of proteins cause nemaline myopathy. To study the pathobiology of desmin myopathy I generated three zebrafish models expressing desminL345P, desminI451M, and desminS460I. Expression of mutant desmin resulted in the formation of aggregates in the skeletal muscle and presence of mitochondria in the myofibrils, recapitulating the patients’ pathology. Expression of desminS460I resulted in a more severe pathology than in the other transgenic lines, with clear disruption of the muscle fibres, formation of aggregates and Z-disc thickening, and also impaired swimming behaviour, suggesting the pathological features and muscle function may be related. This is the first model for desmin myopathy showing impaired muscle function in vivo. Here I show the generation of zebrafish models for KLHL40 nemaline myopathy with foetal akinesia and three models for desmin myopathy. I also found that loss of klhl31 results in a pathology that resembles nemaline myopathy with foetal akinesia, suggesting that mutations in KLHL31 may also result in this myopathy. These animal models can be used to further understand disease mechanisms and ultimately used to test for compounds that may improve the function of the muscle.

Zebrafish as a model to investigate a biallelic gain-of-function variant in MSGN1, associated with a novel skeletal dysplasia syndrome

ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic oto-facial malformations

Characterizing CSNK2A1 Mutant-Induced Morphological Phenotypes in Zebrafish (Danio rerio): Insights into Okur-Chung Neurodevelopmental Syndrome (OCNDS)

Characterization of a novel zebrafish model of -associated CMT4B3

Neuromuscular Disorders in Zebrafish: State of the Art and Future Perspectives

A genetic model of CEDNIK syndrome in zebrafish highlights the role of the SNARE protein Snap29 in neuromotor and epidermal development

Comprehensive phenotypic characterization of an allelic series of zebrafish models of NEB-related nemaline myopathy

Zebrafish and cellular models of -Related Myopathy exhibit novel embryonic and metabolic phenotypes

Transcriptome analysis of -null zebrafish embryos elucidates possible disease mechanisms

Biallelic loss-of-function variants in CACHD1 cause a novel neurodevelopmental syndrome with facial dysmorphism and multisystem congenital abnormalities

Generation and characterization of a zebrafish gain-of-function ACOX1 Mitchell disease model

Genetic Modeling of the Neurodegenerative Disease Spinocerebellar Ataxia Type 1 in Zebrafish

Zebrafish models of Mucopolysaccharidosis types IIIA, B, & C show hyperactivity and changes in oligodendrocyte state

Modelling myopathies in zebrafish

Zebrafish Models of Neurodevelopmental Disorders: Past, Present, and Future

Gene identification for ocular congenital cranial motor neuron disorders using human sequencing, zebrafish screening, and protein binding microarrays

Mutation in ZDHHC15 Leads to Hypotonic Cerebral Palsy, Autism, Epilepsy, and Intellectual Disability

Development of a high-throughput tailored imaging method in zebrafish to understand and treat neuromuscular diseases

Variants in ZFX are associated with an X-linked neurodevelopmental disorder with recurrent facial gestalt

Shared and unique consequences of Joubert Syndrome gene dysfunction on the zebrafish central nervous system

Genetic compensation in a stable slc25a46 mutant zebrafish: A case for using F0 CRISPR mutagenesis to study phenotypes caused by inherited disease